ARCHIVES

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

ACS Lists Challenges For Global Tobacco Control

January 22, 2010

Children’s Oncology Group to Select New Chairman; Four Leaders to Step Aside

April 28, 2000

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993